Long term complications in patients implanted with subcutaneous implantable defibrillators Real-world data from the Extended ELISIR experience

Heart Rhythm

28 July Jul 2021 one month ago
  • Tondo C

Recently, the Food and Drug administration issued a recall for the subcutaneous implantable cardioverter defibrillator (S-ICD) due to the possibility of lead ruptures and accelerated battery depletion. Aim of this study is to evaluate device-related complications over time in a real-world multicentered large S-ICD cohort.

Reference

Long term complications in patients implanted with subcutaneous implantable defibrillators Real-world data from the Extended ELISIR experience. Gasperetti A, Schiavone M, Ziacchi M, Vogler J, Breitenstein A, Laredo M, Palmisano P, Ricciardi D, Mitacchione G, Compagnucci P, Bisignani A, Angeletti A, Casella M, Picarelli F, Fink T, Kaiser L, Hakmi S, Calò L, Pignalberi C, Santini L, Lavalle C, Pisanò E, Olivotto I, Tondo C, Curnis A, Russo AD, Badenco N, Steffel J, Love CJ, Tilz R, Forleo G, Biffi M. Heart Rhythm. 2021 Jul 13:S1547-5271(21)01866-X. doi: 10.1016/j.hrthm.2021.07.00

Go to PubMed